<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">The breakthrough discovery of dexamethasone as the first drug to save lives is very encouraging. It enlightens the hope to reduce the mortality in critically ill hospitalized patients. Though the drug is found to be effective in only patients on ventilators or oxygen, the overall impact on reducing the mortality will be huge because critically ill patients are the great contributors to the COVID-19 death toll. Furthermore, the comparatively low price and worldwide availability of the drug will contribute to the reduction worries caused by the pandemic. The drug will prove a boon for low and middle-income countries where an effective but expensive drug would be beyond the financial reach of the general population [
 <xref rid="bib6" ref-type="bibr">6</xref>]. However, finding effective drugs like dexamethasone will transform the global impact of the COVID-19 pandemic on lives and economies. However, the goal is not yet achieved, and an effective vaccine and treatment are still awaited to counter this pandemic.
</p>
